Regulators worldwide take action on ranitidine

27 September 2019 - Deborah Wilkes

Premium

Regulatory agencies around the world are taking action on medicines containing ranitidine after tests showed some contain "low levels" of a probable human carcinogen called N-nitrosodimethylamine (NDMA).

Click tags below for more information on topics:

EMA FDA TGA Medsafe Ranitidine

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: